Understanding NOX2 in Alcohol-Related Liver Damage
Role of neutrophil-specific NOX2 in alcohol-induced liver injury
This project looks at how a specific protein in immune cells, called NOX2, affects liver damage caused by alcohol, hoping to find new ways to help people with alcoholic liver disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11132681 on NIH RePORTER |
What this research studies
Alcohol-related liver disease affects many people and can lead to serious conditions like cirrhosis. We know that certain immune cells, called neutrophils, build up in the liver and contribute to this damage. This project focuses on a protein within these neutrophils, NOX2, which seems to play a complex role in controlling inflammation. By understanding how NOX2 works in these cells, we hope to uncover new strategies to protect the liver from alcohol-induced injury.
Who could benefit from this research
Good fit: Patients with alcoholic liver disease, particularly those with advanced cirrhosis or alcoholic hepatitis, could potentially benefit from future therapies developed from this research.
Not a fit: Patients whose liver injury is not related to alcohol consumption would likely not benefit from treatments specifically targeting alcohol-induced mechanisms.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that specifically target immune cells to reduce liver damage for patients with alcohol-related liver disease.
How similar studies have performed: Recent discoveries have highlighted the complex role of NOX2 in inflammation, and preliminary data from this team suggest a specific impact in alcohol-related liver injury.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Ju, Cynthia — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Ju, Cynthia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.